If you’ve been following the world of gut health, you’ve probably heard a lot about probiotics and fiber. Maybe you’ve already tried a few supplements, switched to sourdough bread, or started adding sauerkraut to your weekly groceries. These are all sensible steps, but the science of gut health goes far beyond the basics. Researchers are now turning to a rather unexpected source for the next generation of gut support: human breast milk.
In particular, two bioactive compounds naturally found in breast milk (Human Milk Oligosaccharides (HMOs) and lactoferrin) are generating significant excitement in the scientific community. Long recognized as essential for infant development, these molecules are now being studied for their remarkable potential to support gut health, boost immunity and restore microbial balance in adults. And for the first time they are available together in one supplement.
What are human milk oligosaccharides (HMOs)?
Human milk oligosaccharides are complex sugars that represent the third most abundant solid component of breast milk, after lactose and fat. There are over 200 different HMO structures, and this is what makes them fascinating: they are completely unpalatable to the child. The baby cannot break them off at all. So why does the body invest so much energy in producing it?
The answer lies in the gut microbiome. HMOs travel intact through the digestive system and end up in the large intestine, where they serve as a highly selective fuel source for beneficial bacteria, especially species Bifidobacterium. Unlike traditional prebiotics like inulin or fructo-oligosaccharides (FOS), which feed a wide range of gut bacteria (including some less desirable ones), HMOs are remarkably precise about the organisms they feed (Elison et al., 2016).
This selectivity is of great importance. In a landmark randomized, placebo-controlled trial of 100 healthy adults, supplementation with the HMO 2′-fucosyllactose (2′-FL) led to significant increases in blood pressure. Bifidobacterium populations and a corresponding reduction in potentially harmful Proteobacteria, all within just two weeks. The study also confirmed that HMO supplementation in doses up to 20 grams per day was safe and well tolerated (Elison et al., 2016).
Healthcare organizations go beyond the microbiome
The benefits of healthcare organizations extend far beyond just feeding good bacteria. Research using advanced intestinal simulation models has shown that healthcare facilities help strengthen the intestinal barrier, the critical layer that separates the contents of your intestines from the rest of your body. When this barrier is compromised (a condition often called ‘leaky gut’), it can cause widespread inflammation and immune dysfunction (Šuligoj et al., 2020).
Healthcare organizations have also been shown to directly help modulate inflammatory responses. A 2024 study published in mBio showed that oral supplementation with 2′-FL significantly reduced markers of intestinal inflammation in experimental models of inflammatory bowel disease, restoring microbial balance and protecting the intestinal wall (Schalich et al., 2024).
This dual action, which selectively feeds beneficial bacteria while supporting the intestinal barrier and calming inflammation, is what sets HMOs apart from conventional prebiotics. It’s also why scientists are increasingly considering them not just as a child’s food, but as a powerful tool for adult gut health.
Enter Lactoferrin: The Immune Guardian
The second breakthrough ingredient from breast milk is lactoferrin, an iron-binding glycoprotein that plays a central role in innate immunity. Lactoferrin is found in high concentrations in colostrum (the first milk produced after birth) and is present in tears, saliva and nasal secretions, primarily wherever the body needs first-line immune defense.
What makes lactoferrin so remarkable is its versatility. It has been shown to possess antimicrobial, antiviral, anti-inflammatory and immunomodulatory properties. In a comprehensive review by Legrand (2016), lactoferrin is described as “the most polyvalent protein present in host defense,” noting its ability to both activate immune cells when threats are present and calm excessive inflammation when the danger has passed (Legrand, 2016).
Specifically in the intestines, lactoferrin supports the integrity of the intestinal barrier, helps regulate the balance between beneficial and harmful bacteria, and promotes healthy iron absorption without feeding pathogenic organisms. Research has confirmed that lactoferrin enhances the expression of tight junction proteins in the intestinal wall, the molecular ‘seals’ between cells that prevent unwanted substances from leaking through (Ochoa & Sizonenko, 2017).
Until recently, supplemental lactoferrin was extracted exclusively from bovine milk (cow’s milk). Although bovine lactoferrin shares some structural similarities with the human form, the two are not identical. A new generation of recombinant human lactoferrin (known as effera™) is now produced through precision fermentation, creating a molecule that is structurally identical to the lactoferrin found in human breast milk. This represents a significant advance in bioactive nutrition.
The synergy effect: why healthcare organizations and lactoferrin work better together
Perhaps the most compelling aspect of this science is what happens when HMOs and lactoferrin are combined. In breast milk, these two bioactive substances do not act separately, but function as part of an integrated system designed to protect and develop infants’ intestines. Researchers now recognize that this same synergy could have enormous potential for adult health.
Consider how the mechanisms complement each other. Healthcare organizations selectively feed beneficially Bifidobacterium species, creating a microbiome that crowds out harmful organisms. Meanwhile, lactoferrin provides direct antimicrobial activity against pathogens, supports the physical integrity of the intestinal barrier and modulates immune responses. Together they tackle intestinal health from multiple angles simultaneously: the microbiome, the barrier and the immune system (Wiertsema et al., 2021).
This multi-layered approach is fundamentally different from using a single-strain probiotic or a basic prebiotic fiber. Rather than introducing external bacteria that may or may not survive the journey through your digestive system, this strategy works with your body’s own biology, feeding the beneficial bacteria you already have while boosting your gut’s natural defenses.
From laboratory to everyday life
Historically, the challenge has been access. HMOs are complex molecules that are difficult and expensive to produce, and human-identical lactoferrin was simply not available as a supplement ingredient. That has now changed.
Advances in precision fermentation and biotechnology have made it possible to produce both HMOs and recombinant human lactoferrin (effera™) at scale, opening the door to innovative supplement formulations. One brand leading this charge is kēposwhich has developed the first supplement that combines HMOs with human-identical lactoferrin specifically for adult gut health. By bringing these two bioactives together in a single daily formula, kēpos makes the protective biology of breast milk accessible to adults for the first time.
For anyone struggling with digestive issues, recurring bloating, or simply looking to take a more science-based approach to gut health, this represents a truly new category of supplementation, one rooted not in trends, but in decades of research into the most advanced nutritional system nature has ever designed.
Practical takeaways
So what does this all mean for your daily wellness routine? Here are some important points to consider:
- Not all prebiotics are created equal. Traditional prebiotics such as inulin and FOS nourish a broad spectrum of intestinal bacteria. Healthcare organizations are much more selective and mainly promote the growth of useful crops Bifidobacterium species without feeding less desirable organisms.
- Gut health is more than just bacteria. A truly comprehensive approach focuses on the microbiome, the intestinal barrier and the immune system together. The combination of HMOs and lactoferrin does exactly this.
- Source is important. Human-identical lactoferrin (such as effera™) better reflects what the body naturally produces, compared to the bovine-derived forms often found in supplements.
- The science is robust. The benefits of HMOs and lactoferrin are supported by randomized controlled trials and peer-reviewed research, not just anecdotal evidence.
- Small changes can have big consequences. Adding targeted bioactives like HMOs and lactoferrin to your routine can help support digestive comfort, immune resilience, and long-term gut health.
The future of gut health is already here
We are experiencing a remarkable moment in nutritional science. The same bioactive compounds that have protected and nourished human babies for millennia are now being unlocked for the health of adults. HMOs and lactoferrin represent not only an evolution in gut health supplementation, but a return to basic biological principles: working with the body rather than against it.
As our understanding of the gut microbiome deepens, one thing has become abundantly clear: the future of gut health is not about more bacteria in a capsule. It’s about providing your body with the precise biological tools it needs to thrive. And those aids, it turns out, were in breast milk all along.
References
- Elison S, Vigsnaes LK, Rindom Krogsgaard L, et al. Oral supplementation of healthy adults with 2′-O-fucosyllactose and lacto-N-neotetraose is well tolerated and alters the gut microbiota. Brother J Nutr. 2016;116(8):1356–1368.
- Šuligoj T, Vigsnæs LK, Van den Abbeele P, et al. Effects of human milk oligosaccharides on the intestinal microbiota and barrier function of adults. Nutrients. 2020;12(9):2808.
- Schalich KM, Buber MT, Engstrom M, et al. An oligosaccharide from breast milk prevents intestinal inflammation in adulthood. mBio. 2024;15(4):e00298-24.
- Legrand D. Overview of Lactoferrin as a Natural Immune Modulator. J Pediatrician. 2016;173 Supplement:S10–S15.
- Ochoa TJ, Sizonenko SV. Lactoferrin and preterm labor: a promising milk protein? Biochem Celbiol. 2017;95(1):22–30.
- Wiertsema SP, van Bergenhenegouwen J, Garssen J, Knippels LMJ. The interplay between the gut microbiome and the immune system in the context of infectious diseases across the lifespan and the role of nutrition in optimizing treatment strategies. Nutrients. 2021;13(3):886.
Author biography
The kēpos scientific team is committed to advancing the understanding and application of human milk bioactives for adult health. Based on the latest peer-reviewed research, kēpos has developed the first supplement that combines Human Milk Oligosaccharides (HMOs) with human-identical lactoferrin (effera™), bringing the protective biology of breast milk to adults. More information at trykepos.com.
